1996
DOI: 10.1097/00008390-199606000-00003
|View full text |Cite
|
Sign up to set email alerts
|

MEL-P, a GM-CSF-producing human melanoma cell line

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
3
0

Year Published

1998
1998
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 0 publications
1
3
0
Order By: Relevance
“…Transduction of MCA106 with the GM-CSF gene did not alter the surface phenotype, except for a minor reduction in the expression of class I MHC antigens. This is in agreement with Ciotti et al [42], who reported the reduction of MHC class I expression in a modified melanoma cell line after GM-CSF secretion had attained high levels. MHC class I molecules are known to present tumor antigens to CD8 + T-cells, which can stimulate cytolytic responses [28].…”
Section: Discussionsupporting
confidence: 93%
“…Transduction of MCA106 with the GM-CSF gene did not alter the surface phenotype, except for a minor reduction in the expression of class I MHC antigens. This is in agreement with Ciotti et al [42], who reported the reduction of MHC class I expression in a modified melanoma cell line after GM-CSF secretion had attained high levels. MHC class I molecules are known to present tumor antigens to CD8 + T-cells, which can stimulate cytolytic responses [28].…”
Section: Discussionsupporting
confidence: 93%
“…In addition all three cell lines secrete molecules such as IL-8 and CXCL-1 (Figure 5). We demonstrated that cells positive for surface expression of ICAM-1 (data not shown) also secrete sICAM-1, which has been extensively published as being up regulated in many tumors [25], notably in melanoma where it has been shown to be associated with disease progression [26,27] and proposed as a prognosis marker [28,29]. Of interest, and to corroborate with our hypothesis, cell lines expressing high amounts of GM-CSF were displaying metastatic competence and invasion [30,31].…”
Section: Resultsmentioning
confidence: 99%
“…In contrast, a number of solid tumour types constitutively express GM‐CSF including skin, head and neck squamous cell carcinoma, gliomas and meningiomas, often in conjunction with G‐CSF 10–13. Studies in vitro and in vivo have shown that GM‐CSF expression in tumour cells, endothelial cells and keratinocytes increases their proliferation and migration12, 14–17 and in vivo expression by tumour cells contributes to increased malignancy, angiogenesis and infiltration of stroma and macrophages 18. As endogenous unregulated production of GM‐CSF by some tumour types correlates with poor prognosis, it is therefore important to study how GM‐CSF may impact on various aspects of tumour growth and development, which may shed light on potential pitfalls in its use as a therapy adjuvant.…”
mentioning
confidence: 99%